help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hoffmann, S. H.
Right arrow Articles by Beckers, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hoffmann, S. H.
Right arrow Articles by Beckers, T.
Molecular Endocrinology 14 (7):1099
Copyright © 2000 by The Endocrine Society

Residues within Transmembrane Helices 2 and 5 of the Human Gonadotropin-Releasing Hormone Receptor Contribute to Agonist and Antagonist Binding

Silke H. Hoffmann, Ton ter Laak1, Ronald Kühne, Helmut Reiländer and Thomas Beckers

Department of Cancer Research (S.H.H., T.B.) ASTA Medica AG D-60314 Frankfurt/Main, Germany
Department of Molecular Membrane Biology (S.H.H., H.R.) Max-Planck-Institute of Biophysics D-60528 Frankfurt/Main, Germany
Institute of Molecular Pharmacology (T.t.L., R.K.) D-10315 Berlin, Germany

To understand the ligand binding properties of the human GnRH receptor (hGnRH-R), 24 site-specific mutants within transmembrane helices (TMH) 1, 2, and 5 and the extracellular loop 2 (E2) were generated. These mutants were analyzed by using a functional reporter gene assay, monitoring receptor signaling via adenylate cyclase to a cAMP-responsive element fused to Photinus pyralis luciferase. The functional behavior of 14 receptor mutants, capable of G-protein coupling and signaling, was studied in detail with different well described agonistic and antagonistic peptide ligands. Furthermore, the binding constants were determined in displacement binding experiments with the antagonist [125I]Cetrorelix.

The substitution of residues K36, Q204, W205, H207, Q208, F210, F213, F216, and S217 for alanine had no or only a marginal effect on ligand binding and signaling. In contrast, substitution of N87, E90, D98, R179, W206, Y211, F214, and T215 for alanine resulted in receptor proteins neither capable of ligand binding nor signal transduction. Within those mutants affecting ligand binding and signaling to various degrees, W101A, N102A, and N212Q differentiate between agonists and antagonists. Thus, in addition to N102 already described, the residues W101 in TMH2 and N212 in TMH5 are important for the architecture of the ligand-binding pocket. Based on the experimental data, three-dimensional models for binding of the superagonist D-Trp6-GnRH (Triptorelin) and the antagonist Cetrorelix to the hGnRH-R are proposed. Both decapeptidic ligands are bound to the receptor in a bent conformation with distinct interactions within the binding pocket formed by all TMHs, E2, and E3. The antagonist Cetrorelix with bulky hydrophobic N-terminal amino acids interacts with quite different receptor residues, a hint at the failure to induce an active, G protein-coupling receptor conformation.




This article has been cited by other articles:


Home page
EndocrinologyHome page
J. A. Tello and N. M. Sherwood
Amphioxus: Beginning of Vertebrate and End of Invertebrate Type GnRH Receptor Lineage
Endocrinology, June 1, 2009; 150(6): 2847 - 2856.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
R. Lopez de Maturana, A. J. Pawson, Z.-L. Lu, L. Davidson, S. Maudsley, K. Morgan, S. P. Langdon, and R. P. Millar
Gonadotropin-Releasing Hormone Analog Structural Determinants of Selectivity for Inhibition of Cell Growth: Support for the Concept of Ligand-Induced Selective Signaling
Mol. Endocrinol., July 1, 2008; 22(7): 1711 - 1722.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
K. D. G. Pfleger, A. J. Pawson, and R. P. Millar
Changes to Gonadotropin-Releasing Hormone (GnRH) Receptor Extracellular Loops Differentially Affect GnRH Analog Binding and Activation: Evidence for Distinct Ligand-Stabilized Receptor Conformations
Endocrinology, June 1, 2008; 149(6): 3118 - 3129.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
A. J. Stewart, R. Sellar, D. J. Wilson, R. P. Millar, and Z.-L. Lu
Identification of a Novel Ligand Binding Residue Arg38(1.35) in the Human Gonadotropin-Releasing Hormone Receptor
Mol. Pharmacol., January 1, 2008; 73(1): 75 - 81.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
S. Mamputha, Z.-l. Lu, R. W. Roeske, R. P. Millar, A. A. Katz, and C. A. Flanagan
Conserved Amino Acid Residues that Are Important for Ligand Binding in the Type I Gonadotropin-Releasing Hormone (GnRH) Receptor Are Required for High Potency of GnRH II at the Type II GnRH Receptor
Mol. Endocrinol., January 1, 2007; 21(1): 281 - 292.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F. T. Khasawneh, J.-S. Huang, J. W. Turek, and G. C. L. Breton
Differential Mapping of the Amino Acids Mediating Agonist and Antagonist Coordination with the Human Thromboxane A2 Receptor Protein
J. Biol. Chem., September 15, 2006; 281(37): 26951 - 26965.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
P. E. Barran, R. W. Roeske, A. J. Pawson, R. Sellar, M. T. Bowers, K. Morgan, Z.-L. Lu, M. Tsuda, T. Kusakabe, and R. P. Millar
Evolution of Constrained Gonadotropin-releasing Hormone Ligand Conformation and Receptor Selectivity
J. Biol. Chem., November 18, 2005; 280(46): 38569 - 38575.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
J. A. Tello, J. E. Rivier, and N. M. Sherwood
Tunicate Gonadotropin-Releasing Hormone (GnRH) Peptides Selectively Activate Ciona intestinalis GnRH Receptors and the Green Monkey Type II GnRH Receptor
Endocrinology, September 1, 2005; 146(9): 4061 - 4073.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
C. K. Cheng and P. C. K. Leung
Molecular Biology of Gonadotropin-Releasing Hormone (GnRH)-I, GnRH-II, and Their Receptors in Humans
Endocr. Rev., April 1, 2005; 26(2): 283 - 306.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
J. H. Li, H. Choe, A. F. Wang, K. Maiti, C. Wang, A. Salam, S. Y. Chun, W.-K. Lee, K. Kim, H. B. Kwon, et al.
Extracellular Loop 3 (EL3) and EL3-Proximal Transmembrane Helix 7 of the Mammalian Type I and Type II Gonadotropin-Releasing Hormone (GnRH) Receptors Determine Differential Ligand Selectivity to GnRH-I and GnRH-II
Mol. Pharmacol., April 1, 2005; 67(4): 1099 - 1110.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
R. P. Millar, Z.-L. Lu, A. J. Pawson, C. A. Flanagan, K. Morgan, and S. R. Maudsley
Gonadotropin-Releasing Hormone Receptors
Endocr. Rev., April 1, 2004; 25(2): 235 - 275.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
C. Wang, O. Yun, K. Maiti, D. Y. Oh, K. K. Kim, C. H. Chae, C. J. Lee, J. Y. Seong, and H. B. Kwon
Position of Pro and Ser near Glu7.32 in the Extracellular Loop 3 of Mammalian and Nonmammalian Gonadotropin-Releasing Hormone (GnRH) Receptors Is a Critical Determinant for Differential Ligand Selectivity for Mammalian GnRH and Chicken GnRH-II
Mol. Endocrinol., January 1, 2004; 18(1): 105 - 116.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
B. Karges, W. Karges, M. Mine, L. Ludwig, R. Kuhne, E. Milgrom, and N. de Roux
Mutation Ala171Thr Stabilizes the Gonadotropin-Releasing Hormone Receptor in Its Inactive Conformation, Causing Familial Hypogonadotropic Hypogonadism
J. Clin. Endocrinol. Metab., April 1, 2003; 88(4): 1873 - 1879.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
J. Y. Seong, L. Wang, D. Y. Oh, O. Yun, K. Maiti, J. H. Li, J. M. Soh, H. S. Choi, K. Kim, H. Vaudry, et al.
Ala/Thr201 in Extracellular Loop 2 and Leu/Phe290 in Transmembrane Domain 6 of Type 1 Frog Gonadotropin-Releasing Hormone Receptor Confer Differential Ligand Sensitivity and Signal Transduction
Endocrinology, February 1, 2003; 144(2): 454 - 466.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
T. R. Ott, B. E. Troskie, R. W. Roeske, N. Illing, C. A. Flanagan, and R. P. Millar
Two Mutations in Extracellular Loop 2 of the Human GnRH Receptor Convert an Antagonist to an Agonist
Mol. Endocrinol., May 1, 2002; 16(5): 1079 - 1088.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
B. J. Fromme, A. A. Katz, R. W. Roeske, R. P. Millar, and C. A. Flanagan
Role of Aspartate7.32(302) of the Human Gonadotropin-Releasing Hormone Receptor in Stabilizing a High-Affinity Ligand Conformation
Mol. Pharmacol., December 1, 2001; 60(6): 1280 - 1287.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
L. Wang, D. Y. Oh, J. Bogerd, H. S. Choi, R. S. Ahn, J. Y. Seong, and H. B. Kwon
Inhibitory Activity of Alternative Splice Variants of the Bullfrog GnRH Receptor-3 on Wild-Type Receptor Signaling
Endocrinology, September 1, 2001; 142(9): 4015 - 4025.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
R. D. Horvat, D. A. Roess, S. E. Nelson, B. G. Barisas, and C. M. Clay
Binding of Agonist but Not Antagonist Leads to Fluorescence Resonance Energy Transfer between Intrinsically Fluorescent Gonadotropin-Releasing Hormone Receptors
Mol. Endocrinol., May 1, 2001; 15(5): 695 - 703.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
M. C. Gershengorn and R. Osman
Minireview: Insights into G Protein-Coupled Receptor Function Using Molecular Models
Endocrinology, January 1, 2001; 142(1): 2 - 10.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2000 by The Endocrine Society